www.fdanews.com/articles/67087-recojet-test-marketed-in-india
RECOJET TEST MARKETED IN INDIA
January 3, 2005
Antares Pharma has announced that initial sales of recombinant human insulin along with Antares Pharma's needle-free injection device, the Medi-Jector VISION, have begun in India under the trade name Recojet. Recojet combines Antares Pharma's VISION needle-free injection technology with recombinant human insulin supplied by Singapore-based SciGen, under the local brand name of Recosulin, and is distributed by Mumbai, India-based Shreya Life Sciences.
PharmaLive